Taking advantage of drug resistance, a new approach in the war on cancer
12
The work of the authors is supported by the Oncode Institute,which is financed in part by the Dutch Cancer Society;by the gravitation program CancerGenomics.nl from the Netherlands Organisation for Scientific Research
2018-10-15(万方平台首次上网日期,不代表论文的发表时间)
共6页
490-495